Building a patient group with Crohn disease or ulcerative colitis to predict outcomes
Builds a cohort of people with Crohn disease or ulcerative colitis to predict treatment response.
Plain-language title generated from the registry record
Registry title: Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
Key facts
- Where
- Seoul, South KoreaSee the site
Where in South Korea
- Seoul National University HospitalSeoul, South KoreaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Seoul National University Hospital
- Trial code
- NCT07166588
- Record updated
- 15 September 2025
- Original description
This study aims to establish an integrated cohort of patients with inflammatory bowel disease (IBD) from Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul National University Bundang Hospital. Through this cohort, we seek to develop a prognostic prediction model for IBD patients and a predictive model for therapeutic responses to biologic agents and small molecule therapies.Read full original descriptionShow less
Convergence Research Platform for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
This study aims to establish an integrated cohort of patients with inflammatory bowel disease (IBD) from Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul National University Bundang Hospital. Through this cohort, we seek to develop a prognostic prediction model for IBD patients and a predictive model for therapeutic responses to biologic agents and small molecule therapies.
Inclusion: Patients aged 10 years or older who have been newly diagnosed with inflammatory bowel disease or are under follow-up monitoring.
Exclusion: Patients diagnosed with cancer or with a history of cancer treatment; Infants and young children under the age of 10; Participation may be restricted at the discretion of the medical team.